SW620È˽᳦°©Ï¸°û(DMEM)
»ù±¾ÐÅÏ¢
²úÆ·Æ·ÅÆ £º ½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual MeetingÉúÎï
ÖÐÎÄÃû³Æ £º È˽᳦°©Ï¸°û
ϸ°û¼ò³Æ £º SW 620
ϸ°ûÐÎ̬ £º ÉÏÆ¤Ï¸°ûÑù
Éú³¤ÌØÐÔ £º Ìù±Úϸ°û
ÅàÑø»·¾³ £º ¿ÕÆø£¬95% £»CO2£¬5% 37¡æ
¶³´æÌõ¼þ £º 55% »ù´¡ÅàÑø»ù+40% FBS+5% DMSOÒºµª
ÍêÈ«ÅàÑø»ù £º DMEM (PM150210)£«10% FBS(164210-50)£«1% P/S(PB180120)
´«´ú²½Öè
1¡¢Îü³öÔÅàÑøÒº¡£
2¡¢¼ÓÈë2ml×óÓÒPBS£¬ÇáÇá»Î¶¯ÅàÑøÆ¿Èóϴϸ°û,Îü³öPBS¶ªÆú¡£
3¡¢¼ÓÈë1ml×óÓÒ0.25% Òȵ°°×øÈÜÒº£¨º¬ED TA £©£¬ÇáÇá»Î¶¯ÅàÑøÆ¿Ê¹Ö®½þÈóËùÓÐϸ°û¡£4¡¢·ÅÈëÅàÑøÏäÏû»¯£¬ÏÔ΢¾µÏ¿´µ½Ï¸°û¿éÖмäµÄϸ°ûÃ÷ÏÔ±äÔ²Óмä϶ʱ¿ÉÖÕÖ¹£¬È«³Ì²»ÒªÅÄ´òÅàÑøÆ¿¡£
5¡¢¼ÓÈë3mlº¬ÑªÇåµÄÅàÑø»ùÖÕÖ¹Ïû»¯£¬´µ´òϸ°ûʹ֮Íѱڲ¢ÔÚÒºÌåÀï·´¸´´µ´òʹϸ°û¾¡Á¿³Êµ¥¿Åϸ°ûµÄÐü¸¡Òº¡£
6¡¢ÊÕ¼¯Ï¸°ûÐüÒºÀëÐÄ£¬1200rpm /min 3·ÖÖÓ£¬ÀëÐÄÍêÎü³öÉÏÇ嶪Æú¡£
7¡¢¼ÓÈëÐÂÏÊÅàÑø»ù£¬´µ´ò¼¸Ï»ìÔÈϸ°û¼´¿É£¬°´±ÈÀý½ÓÖÖµ½ÐÂÅàÑøÆ¿£¬²¹×ãÅàÑø»ù£¬Å¡ËÉÆ¿¸Ç»òʹÓÃÍ¸ÆøÆ¿¸Ç½øÐÐÅàÑø¡£
Ïû»¯Ê±¼ä £º 2~ 3·ÖÖÓ
»»ÒºÆµ´Î £º 2~ 3´Î/ÖÜ
´«´ú±ÈÀý£¨Ãܶȣ© £º 1:3-1:4
ϸ°û±³¾°ÃèÊö
SW 620ϸ°ûÊÇ´ÓÒ»¸ö51ËêÄÐÐÔ°×ÈË×éÖ¯ÖзÖÀëµÃµ½µÄ£¬ÓÉA?LeibovitzµÈ´ÓÒ»¸öÁܰͽὨÖê¡£SW 620ϸ°ûÖ÷ÒªÓÉÎÞÈÞëµÄС԰Çòϸ°ûºÍË«¼«Ï¸°û×é³É;SW 620ϸ°û½öºÏ³ÉÉÙÁ¿°©Åß¿¹Ô(C EA )£¬ÔÚÂãÊóÖÐÓи߶ȵÄÖÂÁöÐÔ¡£
±¶Ôöʱ¼ä £º 20-26Сʱ
×éÖ¯À´Ô´ £º ½áÖ±³¦ÏÙ°©£¬À´×Ô×ªÒÆÁܰͽá
ϸ°ûÀàÐÍ £º Ö×Áöϸ°û
Ö×ÁöÀàÐÍ £º ³¦°©Ï¸°û
Ö Áö ÐÔ £º Yes,in nudemice(Tum orsdeveloped within 21 daysat100% frequ en cy(5/5)in nudemiceinoculated subcutaneouslywith 1¡Á10^7 cells).
¿¹Ô±í´ï £º Blood TypeA ; Rh+
»ùÒò±í´ï £º C arcinoem bryonic antigen (C EA)0.15 ng/10^6 cells/10 days;tran sfo rminggrow th factoralpha;m atrilysin.The cellsare negative forexpression ofC SAp(C SA p-)and colon antigen 3,n egative.The cellsare positive forkeratinbyim m unoperoxidase staining.Thelineispositive forexpression ofc-m yc,K-ras,H -ras,N -ras,M yb,sisand fosoncogenes.
¹©ÌåÄêÁäÄÐÐÔ £º 51Ëê
ÉúÎﰲȫµÈ¼¶ £º 1
ϸ°û±£²ØÖÐÐÄ £º ATCC ; CCL-227ECACC ; 87051203
ÊÕµ½³£ÎÂϸ°ûºóÈçºÎ´¦Àí
ϸ°ûÅàÑøÏêϸ²Ù×÷²½ÖèÇë²ÎÕÕ½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual MeetingÉúÎïϸ°ûÅàÑø²Ù×÷Ö¸ÄÏ
1. ÊÕµ½³£ÎÂϸ°ûºó£¬¼°Ê±ÅÄÕռǼÓÐÎÞ©Һ/Æ¿ÉíÆÆËðÏÖÏó¡£
2. ÓÃ75% ¾Æ¾«²ÁÊÃϸ°ûÅàÑøÆ¿±íÃæ£¬ÏÔ΢¾µÏ¹۲ìϸ°û״̬¡£ÏȲ»Òª´ò¿ªÅàÑøÆ¿¸Ç£¬½«Ï¸°ûÖÃÓÚϸ°ûÅàÑøÏäÄÚ¾²ÖÃÅàÑø2-4Сʱ£¬ÒÔ±ãÎȶ¨Ï¸°û״̬¡£
3. ×ÐϸÔĶÁϸ°û˵Ã÷Ê飬Á˽âϸ°ûÏà¹ØÐÅÏ¢£¬ÈçÌù±ÚÌØÐÔ£¨Ìù±Ú/Ðü¸¡£©¡¢Ï¸°ûÐÎ̬¡¢ËùÓûù´¡ÅàÑø»ù¡¢ÑªÇå±ÈÀý¡¢ËùÐèϸ°ûÒò×Ó¡¢´«´ú±ÈÀý¡¢»»ÒºÆµÂʵȡ£
4. ¾²ÖÃÍê³Éºó£¬È¡³öϸ°ûÅàÑøÆ¿£¬¾µ¼ì¡¢ÅÄÕÕ£¬¼Ç¼ϸ°û״̬£¨ËùÅÄÕÕÆ¬ ½«×÷ΪºóÐø·þÎñÒÀ¾Ý£©£»½¨Òéϸ°û´«´úÅàÑøºó£¬¶¨ÆÚÅÄÕÕ¡¢¼Ç¼ϸ°ûÉú³¤×´Ì¬¡£
5. Èô¹Û²ìµ½Òì³£»òÕß¶Ôϸ°ûÓÐÒÉÎÊ£¬Ç뼰ʱ¸úÎÒÃÇÁªÏµ£»¶ÔÓÚϸ°ûÅàÑø²Ù×÷¼°ÅàÑø×¢ÒâÊÂÏîÓÐÒÉÎʵģ¬¿É¸úÎÒÃǵļ¼ÊõÖ§³Ö½»Á÷¡£